Catalyst
Slingshot members are tracking this event:
Vanda Pharmaceuticals (VNDA) to file NDA for Tradipitant for Gastroparesis to FDA in early 2022
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| VNDA |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Future Window:
Jan 01, 2022 - Mar 31, 2022
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Gastroparesis, Tradipitant, Fda Review
